Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Specialized Laboratory Supplies

Active

Federal

Response Deadline09/21/2026, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract opportunity, titled Specialized Laboratory Supplies, is issued by the National Cancer Institute within the Department of Health and Human Services. The contract focuses on the provision of high-purity chemicals, biological reagents, and custom-fabricated 3D-printed medical prototypes to support prime contractors on SBIR Phase I projects. The selected provider must be capable of manufacturing specific chemical compounds and providing necessary Certificates of Analysis and purity standards, with all physical materials delivered directly to the prime contractor's facility. The opportunity is designated as a Total Small Business Set Aside under NAICS code 325199. It was posted on August 10, 2026, and the deadline for responses is September 21, 2026.

General Info

NCI small business subcontract for high-purity chemicals, reagents, and 3D-printed medical prototypes.

Agency

Department Of Health And Human Services → NIH NciView Agency

NAICS

325199 - All Other Basic Organic Chemical ManufacturingView NAICS

Place of Performance

MD, USA

Set-Aside

SBA

Documents

This scope was carved out of 75N98026R00109.

The full solicitation package (5 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 10

subcontract

Response DeadlineSep 21

Submission deadline

Response Deadline

09/21/2026, 09:00:00 PM UTCin 11 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → NIH Nci

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Health And Human Services → NIH Nci

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supplies high-purity chemicals, reagents, and custom-fabricated prototypes for prime contractors on National Cancer Institute (NCI) SBIR Phase I projects. Manufactures specific chemical compounds, biological reagents, or 3D-printed medical prototypes. Provides Certificates of Analysis (CoA) and purity standards. Delivers physical materials and supplies to the prime's facility.

Similar Contracts

Same NAICS industry code

Supply of Chlorine Test Reagent (NSN 6550014607597)

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of pH 4.01 Standard Buffer Solution

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Supply of Dental Sodium Hypochlorite Solution

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sorbent Tube (Chromosorb 106) Supplier

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Lubricating Oil Corrosion Inhibitor (NSN 6850-01-684-6318)

Defense Logistics Agency

POSTED

DEADLINE

Supply of Ultrasonic Test Couplant (NSN 6635-00-966-5246)

ASC SUPPLIER OPER OEM DIVISION

POSTED

DEADLINE

Supply of Pre-filled Trace Metal Grade Sulfuric Acid Vials

Ofc Of Acquisition Grants-Denver

POSTED

DEADLINE

Li/CFx-MnO2 Battery Material Supply

DLA Land At Aberdeen

POSTED

DEADLINE

Solicitation # 140G0226Q0178

RFQ 140G0226Q0178 is a solicitation from the Department of the Interior to establish a single award Blanket Purchase Agreement for the supply of pre-filled acid vials. These materials will support the USGS National Water Quality Laboratory and Water Resource Discipline sampling and testing programs. The agreement is governed by FAR Part 12 for commercial products and services, with a maximum ordering limit of 350,000 dollars over a two-year period of performance running from September 21, 2026, through September 20, 2028. This is not a small business set-aside and falls under NAICS code 325199 for All Other Basic Organic Chemical Manufacturing. Individual purchases will be made via firm-fixed price call orders on an as-needed basis. Prospective vendors must maintain an active registration in the System for Award Management to be eligible for award.

Ofc Of Acquisition Grants-Denver

POSTED

DEADLINE

Substance-Specific Reagent System Supplier

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Electrical Insulating Varnish (NSN 5970-01-480-0614)

AVIATION SUPPLY CHAIN ESOC BUYS

POSTED

DEADLINE

Supplier of Arsenic Water Test Kits

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

More opportunities from Department Of Health And Human Services → NIH Nci

Same awarding agency

Notice of Intent to Award to a Single Source

Solicitation # PCA-NHGRI-10510

The National Human Genome Research Institute intends to award a single-source contract to Meridian BioScience for the procurement of a replacement Breath ID unit and a four-year extended warranty. This acquisition is necessary to replace a malfunctioning unit and ensure the continuity of ongoing research studies that require specific product compatibility. The government is pursuing this on an other-than-full-and-open competition basis under the authority that only one source is available. Although this is a notice of intent rather than a formal request for proposal, interested vendors may submit capability statements and past performance documentation to demonstrate their ability to meet the requirements. Any alternative provider must specifically address the impact of using a non-Meridian BioScience product on the ongoing research studies. All interested parties must reference solicitation number PCA-NHGRI-10510 and submit their responses to Christine Biser by 12:00 pm Eastern Daylight Time on September 16, 2026.

Analytical Laboratory Instrument Manufacturing

POSTED

about 10 hours ago

DEADLINE

Vertebrate Animal Research ServicesThis subcontract for Vertebrate Animal Research Services is issued by the NIH National Cancer Institute under the Department of Health and Human Services. The contract provides prime contractors on SBIR Phase I projects with comprehensive animal research support, including housing, care, and the execution of experimental procedures. Key services encompass animal husbandry, the administration of experimental compounds, and necropsies, all performed within specialized surgical suites and veterinary monitoring systems. The project requires strict adherence to Section 8.7 and mandatory IACUC approvals to ensure ethical and regulatory compliance. The selected provider is responsible for delivering detailed animal study data and tissue samples. This opportunity is a total small business set-aside under NAICS code 541714, with a response deadline of September 21, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 1 month ago

DEADLINE

Contract Research Organization (CRO) / Lab ServicesThis subcontract opportunity is for a Contract Research Organization or laboratory services provider to support prime contractors on National Cancer Institute SBIR Phase I projects. The selected provider will be responsible for executing experimental designs, performing quantitative measurements, and conducting assays using high-throughput screening and sequencing equipment. Key deliverables include raw data, validated test results, and comprehensive technical reports, with some tasks potentially requiring GLP or CLIA certification. The project is issued by the National Institutes of Health under the Department of Health and Human Services and is designated as a total small business set-aside under NAICS code 541714. Interested parties must submit their responses by September 21, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 1 month ago

DEADLINE

Biostatistical Consulting ServicesThis subcontract for Biostatistical Consulting Services supports prime contractors on National Cancer Institute SBIR Phase I projects within the Department of Health and Human Services. The selected provider will be responsible for designing statistical power analyses, processing raw data, and performing quantitative parameter analysis using SAS, R, or SPSS software to deliver validated data sets and comprehensive statistical analysis reports. The opportunity is a total Small Business Set Aside under NAICS code 541690. Qualified candidates must hold a PhD or Master's degree in Biostatistics or Epidemiology. The solicitation was posted on August 10, 2026, with a response deadline of September 21, 2026.

Other Scientific and Technical Consulting Services

POSTED

about 1 month ago

DEADLINE

NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM

Solicitation # 75N98026R00109

The National Cancer Institute (NCI) is soliciting research proposals from small business concerns for its Phase I Small Business Innovation Research (SBIR) Innovative Concept Award Program under solicitation 75N98026R00109. This high-risk, high-reward program focuses on developing transformative technologies for pediatric and rare cancers, specifically targeting those with a five-year survival rate of less than 50 percent. The scope is divided into two primary topics: the development of therapeutic or preventative technologies and the creation of devices, diagnostic technologies, or digital health tools. The program aims to demonstrate proof-of-concept and feasibility for game-changing R&D, and while preliminary data is not required, proposals must be based on a sound scientific premise and identify a clear development path toward a future product. The total funding available per award is up to 300,000 dollars for base R&D, with an additional 6,500 dollars available for Technical and Business Assistance (TABA). Proposals are evaluated through a multi-stage process involving a preliminary triage and a technical review panel. The weighted evaluation criteria include potential for innovation and impact (50 percent), scientific rationale and approach (20 percent), commercialization potential (20 percent), and personnel and resources (10 percent). Non-exempt human subjects research is not supported under this solicitation. Applicants must be registered in the System for Award Management (SAM) and the SBA Company Registry. Submissions must be uploaded via the electronic Contract Proposal Submission (eCPS) portal in three parts: a technical proposal, a business proposal, and the PHS Human Subjects and Clinical Trials Information Form. Following amendments, the Data Management Sharing Plan requirement has been removed, and offerors must include a signed copy of Amendment 3 with their business proposal. The deadline for receipt of proposals is 5:00pm on September 21, 2026.

POSTED

about 1 month ago

DEADLINE

Vehicle Recompete: NCI IT — BPA NCI ITThe National Cancer Institute Information Technology Blanket Purchase Agreement is managed by the Department of Health and Human Services to provide critical and complex IT services supporting scientific, business, and administrative requirements. This full-recompete vehicle has an overall ceiling of 161,183,782.04 dollars and an ordering period that extends through November 8, 2027. Major task orders under this agreement include digital services and solutions foundational support awarded to Deloitte & Touche LLP, software engineering and support awarded to Accenture Federal Services LLC, and IT infrastructure and operations awarded to Octo Consulting Group LLC. Additional significant support is provided by DLH, LLC for desktop management and user support, as well as further systems engineering and cloud platform management services from Deloitte & Touche LLP.

Other Computer Related Services

POSTED

DEADLINE

Vehicle Recompete: Idc 75N91022D00014The Cancer Trials Support Unit (CTSU) IDIQ, contract 75N91022D00014, is a full-recompete vehicle managed by the NIH NCI under the Department of Health and Human Services. This contract features an IDV ceiling of 548 million dollars and is designated as a partial small business set-aside. The ordering period for this vehicle is scheduled to conclude on July 31, 2027. The contract focuses on providing specialized support for cancer trials, with notable activity including centralized protocol writing support and project kickoff services. Technical Resources International, Inc. has been awarded a significant task order valued at over 3.1 million dollars. The vehicle operates under NAICS code 541715 to support the operational needs of the National Cancer Institute.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Vehicle Recompete: Idc 75N91022D00010This contract, identified as 75N91022D00010, is an Indefinite Delivery Contract (IDIC) for tobacco control research scientific and technical services support. Managed by the National Cancer Institute (NCI) under the Department of Health and Human Services, the vehicle is an 8(a) set-aside competed through a full recompete process. The contract has an established ceiling value of $15,000,000 and is scheduled to remain active through an ordering period ending July 31, 2027. Significant task orders under this vehicle have been awarded to Strategix Management LLC, covering diverse requirements such as the development and dissemination of NCI tobacco control monographs, coordination for cancer health equity design workshops, and meeting logistics for the Patient Engagement and Cancer Genome Sequencing network. The contract falls under NAICS code 541990 and serves as a primary vehicle for specialized scientific and technical support related to tobacco control research initiatives.

All Other Professional, Scientific, and Technical Services

POSTED

DEADLINE

Vehicle Recompete: Idc 75N91022D00005Contract 75N91022D00005 is an indefinite delivery contract managed by the NIH NCI under the Department of Health and Human Services to provide field and biospecimen support services for the Division of Cancer Epidemiology and Genetics. This full-recompete vehicle has an IDV ceiling of 320 million dollars and an ordering period that extends through June 30, 2027. The contract was issued without a set-aside and is classified under NAICS code 541715. While there are currently no active task orders listed at zero dollars, previous high-value activity includes a task order for radiation-related cancer studies awarded to Social and Scientific Systems, Inc. for over 1.4 million dollars.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Vehicle Recompete: Idc 75N91022D00006Contract 75N91022D00006 is an Indefinite Delivery Contract managed by the NIH NCI under the Department of Health and Human Services to provide field and biospecimen support services for the Division of Cancer Epidemiology and Genetics. This full-recompete vehicle has an IDV ceiling of 320 million dollars and an ordering period that extends through June 30, 2027. There is no specific set-aside associated with this procurement. Westat, Inc. has been a primary recipient of significant task orders under this vehicle, including clinical, genetic, and epidemiological support services, as well as support for the Occupational and Environmental Epidemiology Branch and the Metabolic Epidemiology Branch. These tasks involve providing technical support and serving as a coordinating center for study activities, with individual task order values ranging from approximately 1 million to over 10 million dollars.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Vehicle Recompete: Idc 75N91022D00002Contract 75N91022D00002 is an indefinite delivery contract managed by the NIH NCI under the Department of Health and Human Services to provide field and biospecimen support services for the Division of Cancer Epidemiology and Genetics. This full-recompete vehicle has an IDV ceiling of 320 million dollars and an ordering period that extends through June 30, 2027. There is no specific set-aside associated with this procurement. A notable task order under this vehicle was awarded to the American Type Culture Collection for biospecimen and assay support services, valued at over 2 million dollars with a performance period ending in September 2029. The contract falls under NAICS code 541715 and was originally solicited under 75N91021R00045.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Vehicle Recompete: Idc 75N91023D00005This contract is an indefinite delivery indefinite quantity (IDIQ) agreement for the procurement of nilotinib tablets to support the U.S. Department of Health and Human Services, specifically the National Institutes of Health (NIH) National Cancer Institute (NCI). The ordering period for this vehicle extends until March 26, 2027, with a total contract ceiling of $6.34 million. It is designated as a total small business set-aside, ensuring that the contract opportunities are exclusively reserved for small businesses. The contract is classified as a recompete-likely, indicating that it is a renewal of a previous contract with moderate confidence. Currently, there are no active task orders under this contract valued at zero, but one notable task order, Delivery Order 4, involved the procurement of 36 blisters of 200 mg nilotinib capsules, valued at approximately $219,850 and awarded to Regimed Medical. The contract is managed through the NIH NCI contracting office and falls under NAICS code 325412, relating to pharmaceutical product manufacturing. This contract ensures a reliable supply of nilotinib tablets to support oncology-related research and treatments conducted or supported by the NCI.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 650+ contractors already using CLEATUS